Work

Wcn25-2336 Iatrogenic Perioperative Hypervolemia: a Novel Unrecognized Etiology of Delayed Renal Allograft Function - Two Case Series

Year: 2025

Type: article

Abstract: hemodynamic deterioration were evident, informing the family that a transfer to the ICU and urgent endoscopy was required.The family decides to stop intervention management, taking her home with palliative care.Medically, it is discussed whether we are facing futile treatment and whether the transplant bridging window had closed.Results: Patients with terminal organ failure as the liver, lung or heart require a multidisciplinary approach and assessment protocols to determine the feasibility and success of transplantation as a curative treatment.The dual plasma molecular adsorption system (DPMAS) has emerged as a relevant option for transplant bridging therapy, sadly many patients reach advanced stages of the disease, which reduces the feasibility of implementing this advanced therapy in a timely manner.Conclusions: Nephrology requires pre and post involvement and also during the transplant, so it is important to know the indications for ECOS (Extracorporeal organ support) with the CRRT platform, a niche in which today the Liver support has evolved significantly.I have no potential conflict of interest to disclose.I did not use generative AI and AI-assisted technologies in the writing process.

Source: Kidney International Reports

DOI: 10.1016/j.ekir.2024.11.096

Authors: Macaulay Onuigbo, Yetunde Olorunfemi, Chibundo Onyia, Cosmas Ihezie

Institutions: University of Vermont, University of Vermont Medical Center

Language: English

Topic: Renal Transplantation Outcomes and Treatments

Subfield: Transplantation

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,800